series-c-plus
Stage
1
Investors
About
Lundbeck is a global pharmaceutical company specializing in brain health and neuroscience, developing treatments for disorders such as depression, schizophrenia, Alzheimer's, Parkinson's disease, and other central nervous system conditions.
Explore Lundbeck's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.